Effectiveness of Baricitinib in Refractory Seronegative Rheumatoid Arthritis and Uveitis: A Case Report.

Kaneko Y, Murakami T, Nishitsuka K, Takakubo Y, Takagi M, Yamashita H

Open source

DOI
10.3389/fmed.2021.764067
Published
2021
Container
Frontiers in medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fmed.2021.764067,
  title = {Effectiveness of Baricitinib in Refractory Seronegative Rheumatoid Arthritis and Uveitis: A Case Report.},
  author = {Kaneko Y and Murakami T and Nishitsuka K and Takakubo Y and Takagi M and Yamashita H},
  year = {2021},
  journal = {Frontiers in medicine},
  doi = {10.3389/fmed.2021.764067},
  url = {https://doi.org/10.3389/fmed.2021.764067}
}

RIS

TY  - JOUR
TI  - Effectiveness of Baricitinib in Refractory Seronegative Rheumatoid Arthritis and Uveitis: A Case Report.
AU  - Kaneko Y
AU  - Murakami T
AU  - Nishitsuka K
AU  - Takakubo Y
AU  - Takagi M
AU  - Yamashita H
PY  - 2021
JO  - Frontiers in medicine
DO  - 10.3389/fmed.2021.764067
UR  - https://doi.org/10.3389/fmed.2021.764067
ER  - 

APA

Y, K., T, M., K, N., Y, T., M, T., & H, Y. (2021). Effectiveness of Baricitinib in Refractory Seronegative Rheumatoid Arthritis and Uveitis: A Case Report.. Frontiers in medicine. https://doi.org/10.3389/fmed.2021.764067

Source records